Alan Mutnick

Alan Howard Mutnick

Assistant Professor - Adjunct

Assistant Professor - Adjunct

Kowalewski Hall

260

Pharmacy Leadership Program - 0004

Education

B.S. Pharmacy: Wayne State University, College of Pharmacy and Allied Health Sciences Detroit, MI, 1976 (Pharmacy)

Pharm.D.: Wayne State University, Graduate College of Pharmacy and Allied Health Professions Detroit, MI, 1978 (Clinical Pharmacy Practice)

Positions and Work Experience

09-11-2017 -To Present Director- Strategic Sourcing/Pharmacy, Memorial Healthcare System, Hollywood, FL

07-05-2007 -08-08-2017 Director- Supply Chain/Pharmacy, Mercy Healthcare System, Cincinnati, OH

Publications

Peer Reviewed Publications

Reeder, Todd A; Mutnick, Alan (2008. ) Pharmacist- versus physician-obtained medication histories.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 65 (9 ) ,857-60 More Information

Rudisill, Celeste N; Hockman, Rebecca H; Degregory, Kathlene A; Mutnick, Alan H; Macik, Barbara Gail (2006. ) Implementing guidelines for the institutional use of factor VIIa (recombinant): a multidisciplinary solution.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 63 (17 ) ,1641-6 More Information

Mutnick, Alan H; Rhomberg, Paul R; Sader, Helio S; Jones, Ronald N (2004. ) Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).The Journal of antimicrobial chemotherapy, , 53 (2 ) ,290-6 More Information

Sader, Helio S; Fritsche, Thomas R; Mutnick, Alan H; Jones, Ronald N (2003. ) Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).Diagnostic microbiology and infectious disease, , 47 (3 ) ,515-25 More Information

Deshpande, L M; Beach, M L; Mutnick, A H; Jones, R N (2003. ) Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, , 9 (8 ) ,893-6 More Information

Mutnick, Alan H; Enne, Victoria; Jones, Ronald N (2003. ) Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program.The Annals of pharmacotherapy, , 37 (6 ) ,769-74 More Information

Schupp, Kelly N; Schrand, Linda M; Mutnick, Alan H (2003. ) A cost-effectiveness analysis of stress ulcer prophylaxis.The Annals of pharmacotherapy, , 37 (5 ) ,631-5 More Information

Mutnick, Alan H; Biedenbach, Douglas J; Jones, Ronald N (2003. ) Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000).Diagnostic microbiology and infectious disease, , 46 (1 ) ,63-8 More Information

Rennie, Robert P; Jones, Ronald N; Mutnick, Alan H (2003. ) Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000).Diagnostic microbiology and infectious disease, , 45 (4 ) ,287-93 More Information

Hoban, Daryl J; Biedenbach, Douglas J; Mutnick, Alan H; Jones, Ronald N (2003. ) Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000).Diagnostic microbiology and infectious disease, , 45 (4 ) ,279-85 More Information

Mutnick, Alan H; Kirby, Jeffrey T; Jones, Ronald N (2003. ) CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance.The Annals of pharmacotherapy, , 37 (1 ) ,47-56 More Information

Jones, Ronald N; Deshpande, Lalitagauri M; Mutnick, Alan H; Biedenbach, Douglas J (2002. ) In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci.The Journal of antimicrobial chemotherapy, , 50 (6 ) ,915-32 More Information

Jones, Ronald N; Mutnick, Alan H; Varnam, David J (2002. ) Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001).Journal of clinical microbiology, , 40 (11 ) ,4332-3 More Information

Kirby, Jeffrey T; Mutnick, Alan H; Jones, Ronald N; Biedenbach, Douglas J; Pfaller, Michael A (2002. ) Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).Diagnostic microbiology and infectious disease, , 43 (4 ) ,303-9 More Information

Gordon, Kelley A; Beach, Mondell L; Biedenbach, Douglas J; Jones, Ronald N; Rhomberg, Paul R; Mutnick, Alan H (2002. ) Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).Diagnostic microbiology and infectious disease, , 43 (2 ) ,157-62 More Information

Mutnick, A H; Turner, P J; Jones, R N (2002. ) Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.Journal of chemotherapy (Florence, Italy), , 14 (3 ) ,253-8 More Information

Mutnick, Alan H; Biedenbach, Douglas J; Turnidge, John D; Jones, Ronald N (2002. ) Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.Diagnostic microbiology and infectious disease, , 43 (1 ) ,65-73 More Information

Schrand, L M; Elliott, J M; Ross, M B; Bell, E F; Mutnick, A H (2001. ) A cost-benefit analysis of RSV prophylaxis in high-risk infants.The Annals of pharmacotherapy, , 35 (10 ) ,1186-93 More Information

Smith, T A; Dillon, D M; Kotula, R J; Mutnick, A H (2001. ) Evaluation of antimicrobial surgical prophylaxis with multiattribute utility theory.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 58 (3 ) ,251-5 More Information

Schrand, L M; Behmer-Miller, K A; Ross, M B; Mutnick, A H (2000. ) Medication use evaluation: a work in progress. Pharmacy practice management quarterly, , 20 (2 ) ,1-15

Berg, M S; Dreher, M; Davenport, K D; Greiner, J; Howell, R E; Mutnick, A H; Jensen, G V; Rakel, B A; Johlin, F C; Kraus, V L; Reiter, R C; Kraus, V L; Leo, K C; Ryan, J; McCloskey, J M; Schlapkohl, M L; Shafer, M E; Szymusiak-Mutnick, B; Titler, M G (1999. ) University of Iowa Hospital and Clinics: outcomes management.Nursing administration quarterly, , 24 (1 ) ,31-65 More Information

McCoy, S; Blayney-Chandramouli, J; Mutnick, A (1998. ) Using multiple pharmacoeconomic methods to conduct a cost-effectiveness analysis of histamine H2-receptor antagonists.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 55 (24 Suppl 4 ) ,S8-12 More Information

Mutnick, A H; Sterba, K J; Szymusiak-Mutnick, B A (1998. ) The integration of quality assessment and a patient-specific intervention/outcomes program. Pharmacy practice management quarterly, , 17 (4 ) ,25-36

Mutnick, A H; Ross, M B (1997. ) Formulary management at a tertiary care teaching hospital. Pharmacy practice management quarterly, , 17 (1 ) ,63-87

Mutnick, A H; Sterba, K J; Peroutka, J A; Sloan, N E; Beltz, E A; Sorenson, M K (1997. ) Cost savings and avoidance from clinical interventions.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 54 (4 ) ,392-6 More Information

Mutnick, A H; Bergquist, S C; Nelson, S P; Bebout, K L (1997. ) The implementation of a pharmaceutical care practice system. Pharmacy practice management quarterly, , 16 (4 ) ,45-52

Mutnick, A; Muscat, J E Primary brain cancer in adults and the use of common household appliances: a case-control study.Reviews on environmental health, , 12 (1 ) ,59-62 More Information

Pilzer, J D; Burke, T G; Mutnick, A H (1996. ) Drug allergy assessment at a university hospital and clinic.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, , 53 (24 ) ,2970-5 More Information

Mutnick, A H; Szymusiak-Mutnick, B A (1996. ) Locally derived clinical practice guidelines using a decision analysis model.AACN clinical issues, , 7 (3 ) ,448-55 More Information

Fain, J; Hilsenrath, P; Widness, J A; Strauss, R G; Mutnick, A H A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity.Transfusion, , 35 (11 ) ,936-43 More Information

Peroutka, J A; Mutnick, A H (1995. ) Use of decision analysis to evaluate the costs and benefits of filgrastim (G-CSF) therapy. Formulary (Cleveland, Ohio), , 30 (7 ) ,394-5, 400-4

Sloan, N E; Peroutka, J A; Morgan, D E; Ross, M B; Mutnick, A H (1994. ) Influencing prescribing practices and associated outcomes utilizing the drug use evaluation process. Topics in hospital pharmacy management, , 14 (3 ) ,1-12

Shireman, T I; Hilsenrath, P E; Strauss, R G; Widness, J A; Mutnick, A H (1994. ) Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.Archives of pediatrics & adolescent medicine, , 148 (6 ) ,582-8 More Information

Szymusiak-Mutnick, B; Mutnick, A H Application of decision analysis in antibiotic formulary choices.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, , 10 (1 ) ,23-6 More Information

Mutnick, A H; Miller, L S (1993. ) The pharmacist as an active member of the institutional review board. Topics in hospital pharmacy management, , 13 (1 ) ,55-7

Burke, T G; Mutnick, A H (1993. ) Ventricular fibrillation and anoxic encephalopathy secondary to astemizole overdose.The Annals of pharmacotherapy, , 27 (2 ) ,239-41 More Information

Drea, E J; Groesch, A A; Hester, F G; Mutnick, A H (1991. ) Clinical strategies in drug therapy selection: an application of "counter-detailing". Topics in hospital pharmacy management, , 11 (2 ) ,70-8

Hester, F G; Gruwell, J B; Mutnick, A H (1990. ) Workplace redesign: meeting the challenge of change while living within your resources. Topics in hospital pharmacy management, , 10 (3 ) ,65-73

Drea, E J; Mutnick, A H; Lam, W; Palazzolo, D P (1990. ) Cimetidine-associated adverse reaction.DICP : the annals of pharmacotherapy, , 24 (6 ) ,581-3 More Information

Mutnick, A H; Szymusiak-Mutnick, B; Drea, E J (1990. ) Dopamine versus dobutamine: are all the facts there? .Pharmacotherapy, , 10 (3 ) ,224-9

Drea, E J; Mutnick, A H (1989. ) Contrast media adverse reactions.DICP : the annals of pharmacotherapy, , 23 (11 ) ,925-6 More Information

Fish, S S; Mattea, E J; Thrasher, K A; Cardoni, A A; Cohen, L G; Gundlach, C; Labreche, D G; Mutnick, A H (1989. ) Clinical pharmacy education in new England: a report of the Whispering Pines Conference.DICP : the annals of pharmacotherapy, , 23 (11 ) ,912-9 More Information

Mutnick, A H; Souney, P F (1988. ) Dobutamine: a drug utilization evaluation. Hospital formulary, , 23 (5 ) ,461-4, 466, 469

Figge, H L; Figge, J; Souney, P F; Mutnick, A H; Sacks, F (1988. ) Nicotinic acid: a review of its clinical use in the treatment of lipid disorders.Pharmacotherapy, , 8 (5 ) ,287-94 More Information

Mutnick, A H; Fecitt, S; Rogers, B (1987. ) Update on cardiac drugs: inotropic and chronotropic agents.Nursing, , 17 (10 ) ,58-61 More Information

Mutnick, A H; Ziccarelli, A; Derouin, C G (1985. ) Documenting pharmacists' services in a hospital pharmacy satellite. American journal of hospital pharmacy, , 42 (9 ) ,1988-9

Mutnick, A; Schneiweiss, F (1982. ) Desipramine-induced pulmonary interstitial eosinophilia.Drug intelligence & clinical pharmacy, , 16 (12 ) ,966-7 More Information

Davis, G L; Mutnick, A H (1981. ) Case study: complications associated with anticoagulant therapy. The American journal of medical technology, , 47 (3 ) ,179-82